AR051390A1 - Derivados de azetidina, pro - Google Patents

Derivados de azetidina, pro

Info

Publication number
AR051390A1
AR051390A1 ARP050104296A ARP050104296A AR051390A1 AR 051390 A1 AR051390 A1 AR 051390A1 AR P050104296 A ARP050104296 A AR P050104296A AR P050104296 A ARP050104296 A AR P050104296A AR 051390 A1 AR051390 A1 AR 051390A1
Authority
AR
Argentina
Prior art keywords
derivatives
azetidina
pro
methylsulfonamide
azetidin
Prior art date
Application number
ARP050104296A
Other languages
English (en)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of AR051390A1 publication Critical patent/AR051390A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Procedimiento de preparacion e derivados de azetidina como el N-{1-[bis-(4-clorofenil)metil]azetidin-3-il}-N-quinol-6-il-metilsulfonamida y de su clorhidrato y del N-{1-[bis-(4-clorofenil)metil]azetidin-3-il}-N-(3,5-difluorofenil)- metilsulfonamida.
ARP050104296A 2004-10-14 2005-10-13 Derivados de azetidina, pro AR051390A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0410844A FR2876688B1 (fr) 2004-10-14 2004-10-14 Nouveau produit, procede et intermediaires de preparation de derives d'azetidine

Publications (1)

Publication Number Publication Date
AR051390A1 true AR051390A1 (es) 2007-01-10

Family

ID=34954419

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050104296A AR051390A1 (es) 2004-10-14 2005-10-13 Derivados de azetidina, pro

Country Status (21)

Country Link
US (1) US7687493B2 (es)
EP (1) EP1805167A2 (es)
JP (1) JP2008516932A (es)
KR (1) KR20070063544A (es)
CN (1) CN101039931A (es)
AR (1) AR051390A1 (es)
AU (1) AU2005293454A1 (es)
BR (1) BRPI0516507A (es)
CA (1) CA2583992A1 (es)
EA (1) EA011408B1 (es)
EC (1) ECSP077332A (es)
FR (1) FR2876688B1 (es)
IL (1) IL181904A0 (es)
MA (1) MA29513B1 (es)
MX (1) MX2007003923A (es)
NO (1) NO20072192L (es)
SG (1) SG155193A1 (es)
TN (1) TNSN07097A1 (es)
TW (1) TW200630358A (es)
WO (1) WO2006040465A2 (es)
ZA (1) ZA200702528B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113045539B (zh) * 2021-03-30 2021-12-07 苏州大学 2-(4,4-二氯-1-(8-喹啉基)-2-氮杂环丁基)羧酸酯衍生物的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8709887D0 (en) * 1987-04-27 1987-06-03 Univ Alberta Alkyl azodicarboxylates
US5530134A (en) * 1994-09-06 1996-06-25 Synphar Laboratories Inc. Synthesis of anabaseine, salts and derivatives thereof
US6355631B1 (en) * 2000-03-03 2002-03-12 Aventis Pharma S.A. Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and their preparation
FR2805817B1 (fr) * 2000-03-03 2002-04-26 Aventis Pharma Sa Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation
BRPI0113146B8 (pt) * 2000-08-10 2021-05-25 Mitsubishi Pharma Corp "derivados de prolina e composição farmacêutica que os compreende".
CN1874991A (zh) * 2003-08-29 2006-12-06 小野药品工业株式会社 能够结合s1p受体的化合物及其药物用途

Also Published As

Publication number Publication date
EA011408B1 (ru) 2009-02-27
MX2007003923A (es) 2007-06-07
SG155193A1 (en) 2009-09-30
KR20070063544A (ko) 2007-06-19
EA200700840A1 (ru) 2007-08-31
ZA200702528B (en) 2008-07-30
FR2876688A1 (fr) 2006-04-21
MA29513B1 (fr) 2008-06-02
TW200630358A (en) 2006-09-01
ECSP077332A (es) 2007-04-26
TNSN07097A1 (fr) 2008-06-02
AU2005293454A1 (en) 2006-04-20
US20070270463A1 (en) 2007-11-22
WO2006040465A2 (fr) 2006-04-20
IL181904A0 (en) 2007-07-04
CN101039931A (zh) 2007-09-19
BRPI0516507A (pt) 2008-09-16
US7687493B2 (en) 2010-03-30
FR2876688B1 (fr) 2007-03-16
CA2583992A1 (fr) 2006-04-20
JP2008516932A (ja) 2008-05-22
WO2006040465A3 (fr) 2006-08-10
NO20072192L (no) 2007-04-27
EP1805167A2 (fr) 2007-07-11

Similar Documents

Publication Publication Date Title
GEP20125666B (en) HYDROXYMETHYL PYRROLIDINES AS β3 ADRENERGIC RECEPTOR AGONISTS
MX2007011023A (es) 2-(4-oxo-4h-quinazolin-3-il) acetamidas y su uso como antagonistas de vasopresin v3.
EA200701114A1 (ru) Азоловые производные с антимускариновой активностью
NZ596024A (en) Indole compounds
ATE537170T1 (de) Cgrp-rezeptorantagonisten
DE602007006961D1 (de) Cgrp-rezeptorantagonisten
CR8481A (es) Derivados de triazol como antagonistas de la vasopresina
GEP20094785B (en) Pyrrolopyrazoles, potent kinase inhibitors
TW200738692A (en) New substituted glycinamides, process for their manufacture and use thereof as medicaments
DE602005012634D1 (en) Arylsulfonylnaphthalinderivate als 5ht2a-antagonisten
NO20081788L (no) Cyklopropylaminer som modulatorer av histamin-H3-reseptoren
DE602005016446D1 (de) 5-HT4-Rezeptoragonistenverbindungen
PE20070490A1 (es) Compuestos derivados de bencimidazol-2-ona sustituidos con piperidina como agonistas del receptor muscarinico m1
EA201170703A1 (ru) Производные адамантилбензамида
MY146623A (en) Substituted prolinamides, manufacturing, and the use thereof as medicaments
NO20084852L (no) MGLUR5 modulatorer V
NO20084007L (no) Spirokondenserte piperidiner som modulatorer av muskarinreseptorer
ATE444990T1 (de) Spritzbare akustikmassen
EP1802372A4 (en) CGRP RECEPTOR ANTAGONISTS)
EA201070689A1 (ru) Композиция для личного ухода
NO20091052L (no) Diaryleterderivater og anvendelser derav
MX2009004947A (es) Arilsulfonil-pirrolidinas como inhibidores 5-hidroxitriptaminas6 (5-ht6).
DE602007013412D1 (de) Therapeutische amide und entsprechende verbindungen
HRP20051005A2 (en) Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives
CR10029A (es) Combinacion de productos activos fungicidas

Legal Events

Date Code Title Description
FB Suspension of granting procedure